Low detection rates of OPTN-indicated corticosteroid use within claims require further examination.
2
Conclusions: This is the first comprehensive study of OPTN in a single West African population.
3
Herein is characterized the agreement of Medicare pharmacy claims for immunosuppressive medications with OPTN reports.
4
Current research from the Organ Procurement and Transplantation Network (OPTN) reveals a continuation of these trends.
5
This study investigated the role of OPTN sequence variants in patients with POAG in Ghana (West Africa).
6
The frequency of alterations in the OPTN gene was analyzed by direct sequencing and enzymatic digestion of PCR products.
7
On average, according to the OPTN, 21 people in the U.S. die each day while waiting for a transplant.
8
Results: All the coding exons of OPTN were sequenced in 140 POAG patients and 130 controls.
9
Our results suggest that coding variants in OPTN may not contribute to the risk for POAG in persons of West African descent.
10
Pretransplant comorbidities derived from administrative claims did not identify factors not collected on OPTN that had a significant impact on graft outcome predictions.
11
However, evaluations of additional CVD-related variables not collected by the OPTN are needed in order to improve the model's accuracy and potential clinical utility.
12
The Organ Procurement and Transplantation Network (OPTN) collects intermittent survey data on immunosuppressive medication use that are studied frequently as research measures.
13
Close agreement of Medicare billing claims and the OPTN for indicated use of nonsteroid immunosuppressive medications supports both as useful measures of drug exposure.